Cargando…

Efficacy of ciclesonide in the treatment of patients with asthma exacerbation

INTRODUCTION: Progressing deterioration of the lung function, dyspnoea, cough, wheezing and chest tightness are the main features of asthma exacerbations. The first step in the prevention of severe asthma exacerbations is to intensify the anti-inflammatory treatment with high doses of inhaled cortic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zietkowski, Ziemowit, Lukaszyk, Mateusz, Skiepko, Roman, Budny, Wojciech, Skiepko, Urszula, Jóźwik, Adam, Bodzenta-Lukaszyk, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627247/ https://www.ncbi.nlm.nih.gov/pubmed/31320857 http://dx.doi.org/10.5114/ada.2019.84596

Ejemplares similares

Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation
por: Skiepko, Roman, et al.
Publicado: (2014)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Endothelin-1 in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction
por: Zietkowski, Ziemowit, et al.
Publicado: (2007)

Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.
por: Zietkowski, Ziemowit, et al.
Publicado: (2010)

GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients
por: Lukaszyk, Ewelina, et al.
Publicado: (2016)

Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease
por: Lukaszyk, Ewelina, et al.
Publicado: (2017)

Fibroblast growth factor 23, iron and inflammation – are they related in early stages of chronic kidney disease?
por: Lukaszyk, Ewelina, et al.
Publicado: (2016)

Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma
por: Kupczyk, Maciej, et al.
Publicado: (2019)

Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study
por: Bodzenta-Lukaszyk, Anna, et al.
Publicado: (2011)

Diagnosis of solitary extramedullary plasmacytoma located in the nasopharynx in a patient with acquired angioedema
por: Czaban, Marcin, et al.
Publicado: (2018)

Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)

Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011)

Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies
por: Rusak, Malgorzata, et al.
Publicado: (2015)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report
por: Moniuszko, Marcin, et al.
Publicado: (2014)

Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma
por: Jamaati, Hamidreza, et al.
Publicado: (2015)

Role of Th17 cells and IL-17, IL-23 cytokines in pathogenesis of autoimmune thyroid disease in children
por: Bossowski, Artur, et al.
Publicado: (2013)

Ciclesonide in persistent asthma: the evidence of its therapeutic value
por: Kenreigh, Charlotte A., et al.
Publicado: (2006)

112 Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Salvi, Sundeep S, et al.
Publicado: (2016)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Barthwal, Madhu Sudan, et al.
Publicado: (2017)

Asthma and exercise-induced respiratory disorders in athletes. The position paper of the Polish Society of Allergology and Polish Society of Sports Medicine
por: Gawlik, Radoslaw, et al.
Publicado: (2019)

Development of Asthmatic Response upon Bronchial Allergen Challenge Is Associated with Dynamic Changes of Interleukin-10-Producing and Interleukin-10-Responding CD4+ T Cells
por: Moniuszko, Marcin, et al.
Publicado: (2014)

Effects of Deoxynivalenol and Zearalenone on the Histology and Ultrastructure of Pig Liver
por: Skiepko, Natalia, et al.
Publicado: (2020)

Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial
por: Pirie, Robert Scott, et al.
Publicado: (2021)

Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008)

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007)

The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2023)

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
por: Postma, Dirkje S., et al.
Publicado: (2017)

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room
por: Martins, Demétrius Tierno, et al.
Publicado: (2022)

Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021)

Monitoring Injuries Associated with Mandated Children’s Products in Australia: What Can the Data Tell Us?
por: Vallmuur, Kirsten, et al.
Publicado: (2018)

The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
por: van der Molen, Thys, et al.
Publicado: (2014)

Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19
por: Dymicka-Piekarska, Violetta, et al.
Publicado: (2023)

Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer
por: Boss, H., et al.
Publicado: (2010)

169 The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media in Atopic Children
por: Nsouli, Safa
Publicado: (2012)

The efficacy and safety of ciclesonide for the treatment of perennial allergic rhinitis: a systematic review and meta-analysis()
por: Yang, Qi, et al.
Publicado: (2018)

Cognitive Functioning of Geriatric Patients: Is Hypovitaminosis D the Next Marker of Cognitive Dysfunction and Dementia?
por: Łukaszyk, Ewelina, et al.
Publicado: (2018)

Identification of Mortality Risks in the Advancement of Old Age: Application of Proportional Hazard Models Based on the Stepwise Variable Selection and the Bayesian Model Averaging Approach
por: Łukaszyk, Ewelina, et al.
Publicado: (2021)

Where to from here? A quality improvement project investigating burns treatment and rehabilitation practices in India
por: Jagnoor, J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b2nbgno1lb6holn7buov9acj56